These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 21332546)

  • 21. Liver and Cardiovascular Damage in Patients With Lean Nonalcoholic Fatty Liver Disease, and Association With Visceral Obesity.
    Fracanzani AL; Petta S; Lombardi R; Pisano G; Russello M; Consonni D; Di Marco V; Cammà C; Mensi L; Dongiovanni P; Valenti L; Craxì A; Fargion S
    Clin Gastroenterol Hepatol; 2017 Oct; 15(10):1604-1611.e1. PubMed ID: 28554682
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of ethnicity on histological differences in non-alcoholic fatty liver disease.
    Mohanty SR; Troy TN; Huo D; O'Brien BL; Jensen DM; Hart J
    J Hepatol; 2009 Apr; 50(4):797-804. PubMed ID: 19231016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients.
    Nakahara T; Hyogo H; Yoneda M; Sumida Y; Eguchi Y; Fujii H; Ono M; Kawaguchi T; Imajo K; Aikata H; Tanaka S; Kanemasa K; Fujimoto K; Anzai K; Saibara T; Sata M; Nakajima A; Itoh Y; Chayama K; Okanoue T;
    J Gastroenterol; 2014 Nov; 49(11):1477-84. PubMed ID: 24277052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; McNeil R; Turner MJ; Han B; Provenzale D; Choi SS; Moylan CA; Hunt CM
    Aliment Pharmacol Ther; 2018 Jan; 47(2):268-278. PubMed ID: 29115682
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency of nonalcoholic fatty liver disease and degree of hepatic steatosis in African-American patients.
    Giday SA; Ashiny Z; Naab T; Smoot D; Banks A
    J Natl Med Assoc; 2006 Oct; 98(10):1613-5. PubMed ID: 17052050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Presence and significance of microvesicular steatosis in nonalcoholic fatty liver disease.
    Tandra S; Yeh MM; Brunt EM; Vuppalanchi R; Cummings OW; Ünalp-Arida A; Wilson LA; Chalasani N
    J Hepatol; 2011 Sep; 55(3):654-659. PubMed ID: 21172393
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial and Ethnic Disparities in Diabetes Screening Between Asian Americans and Other Adults: BRFSS 2012-2014.
    Tung EL; Baig AA; Huang ES; Laiteerapong N; Chua KP
    J Gen Intern Med; 2017 Apr; 32(4):423-429. PubMed ID: 27848187
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histological versus clinical cirrhosis in chronic hepatitis C: does race/ethnicity really matter?
    Kohla M; Iwata S; Ea R; Keyhan S; Taylor R; Yu MC; Groshen S; Bonacini M
    Dig Dis Sci; 2012 Mar; 57(3):771-6. PubMed ID: 21948357
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Validity and reliability of the nonalcoholic fatty liver diseases activity score (NAS) in Korean NAFLD patients and its correlation with clinical factors].
    Lee KH; Park SH; Kim YJ; Huh KR; Min KS; Jun SY; Kim KO; Park CH; Hahn T; Yoo KS; Kim JH; Lee MS; Park CK
    Korean J Hepatol; 2010 Mar; 16(1):29-37. PubMed ID: 20375640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identifying Nonalcoholic Fatty Liver Disease Advanced Fibrosis in the Veterans Health Administration.
    Patel YA; Gifford EJ; Glass LM; Turner MJ; Han B; Moylan CA; Choi S; Suzuki A; Provenzale D; Hunt CM
    Dig Dis Sci; 2018 Sep; 63(9):2259-2266. PubMed ID: 29779083
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease.
    Xun YH; Fan JG; Zang GQ; Liu H; Jiang YM; Xiang J; Huang Q; Shi JP
    J Dig Dis; 2012 Nov; 13(11):588-95. PubMed ID: 23107446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histologically proven non-alcoholic fatty liver disease and clinically related factors in recipients after liver transplantation.
    Kim H; Lee K; Lee KW; Yi NJ; Lee HW; Hong G; Choi Y; You T; Suh SW; Jang JJ; Suh KS
    Clin Transplant; 2014 May; 28(5):521-9. PubMed ID: 24579874
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Racial/ethnic differences in fibrosis prevalence and progression in biopsy-proven steatosis: A focus on the Asian American population.
    Kim RG; Chu JN; Vittinghoff E; Deng J; Reaso JN; Grenert JP; Khalili M
    Hepatol Commun; 2022 Nov; 6(11):3024-3035. PubMed ID: 36087033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled attenuation parameter for the detection and quantification of hepatic steatosis in nonalcoholic fatty liver disease.
    Chan WK; Nik Mustapha NR; Mahadeva S
    J Gastroenterol Hepatol; 2014; 29(7):1470-6. PubMed ID: 24548002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prospective evaluation of the prevalence of non-alcoholic fatty liver disease and steatohepatitis in a large middle-aged US cohort.
    Harrison SA; Gawrieh S; Roberts K; Lisanti CJ; Schwope RB; Cebe KM; Paradis V; Bedossa P; Aldridge Whitehead JM; Labourdette A; Miette V; Neubauer S; Fournier C; Paredes AH; Alkhouri N
    J Hepatol; 2021 Aug; 75(2):284-291. PubMed ID: 33746083
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histological severity of nonalcoholic fatty liver disease is associated with 10-year risk for atherosclerotic cardiovascular disease.
    Park JH; Koo BK; Kim W; Kim WH;
    Hepatol Int; 2021 Oct; 15(5):1148-1159. PubMed ID: 34081289
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study.
    Bhala N; Angulo P; van der Poorten D; Lee E; Hui JM; Saracco G; Adams LA; Charatcharoenwitthaya P; Topping JH; Bugianesi E; Day CP; George J
    Hepatology; 2011 Oct; 54(4):1208-16. PubMed ID: 21688282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Race/Ethnicity-Specific Disparities in the Severity of Disease at Presentation in Adults with Ulcerative Colitis: A Cross-Sectional Study.
    Castaneda G; Liu B; Torres S; Bhuket T; Wong RJ
    Dig Dis Sci; 2017 Oct; 62(10):2876-2881. PubMed ID: 28856475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonalcoholic fatty liver disease in patients with hepatitis C is associated with features of the metabolic syndrome.
    Sanyal AJ; Contos MJ; Sterling RK; Luketic VA; Shiffman ML; Stravitz RT; Mills AS
    Am J Gastroenterol; 2003 Sep; 98(9):2064-71. PubMed ID: 14499789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prevalence of carotid artery stenosis varies significantly by race.
    Rockman CB; Hoang H; Guo Y; Maldonado TS; Jacobowitz GR; Talishinskiy T; Riles TS; Berger JS
    J Vasc Surg; 2013 Feb; 57(2):327-37. PubMed ID: 23177534
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.